Steven L Wood
Overview
Explore the profile of Steven L Wood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wood S, Brown J
Cancers (Basel)
. 2020 Aug;
12(8).
PMID: 32751181
Bone metastasis is a major cause of morbidity within solid tumours of the breast, prostate, lung and kidney. Metastasis to the skeleton is associated with a wide range of complications...
2.
Brown J, Westbrook J, Wood S
Cancer Inform
. 2019 Sep;
18:1176935119866842.
PMID: 31488945
Metastasis to bone occurs in over 70% of patients with advanced breast cancer resulting in skeletal complications, including pathological fractures, hypercalcaemia, and bone pain. Significant advances have been made in...
3.
4.
Westbrook J, Wood S, Cairns D, McMahon K, Gahlaut R, Thygesen H, et al.
J Pathol
. 2018 Nov;
247(3):381-391.
PMID: 30426503
Skeletal metastasis occurs in around 75% of advanced breast cancers, with the disease incurable once cancer cells disseminate to bone, but there remains an unmet need for biomarkers to identify...
5.
Westbrook J, Cairns D, Peng J, Speirs V, Hanby A, Holen I, et al.
J Natl Cancer Inst
. 2016 Jan;
108(4).
PMID: 26757732
Background: Bone is the predominant site of metastasis from breast cancer, and recent trials have demonstrated that adjuvant bisphosphonate therapy can reduce bone metastasis development and improve survival. There is...
6.
Wood S, Pernemalm M, Crosbie P, Whetton A
Cancer Treat Rev
. 2015 Apr;
41(4):361-75.
PMID: 25825324
Lung cancer is the leading cause of cancer-related death worldwide with a 5-year survival rate of less than 15%, despite significant advances in both diagnostic and therapeutic approaches. Combined genomic...
7.
8.
Wood S, Pernemalm M, Crosbie P, Whetton A
Cancer Treat Rev
. 2013 Nov;
40(4):558-66.
PMID: 24176790
Non-small cell lung cancer (NSCLC) accounts for >80% of lung cancer cases and currently has an overall five-year survival rate of only 15%. Patients presenting with advanced stage NSCLC die...
9.
Wood S, Westbrook J, Brown J
Cancer Treat Rev
. 2013 Aug;
40(1):139-52.
PMID: 23958309
Despite well-recognised advances in breast cancer treatment, there remain substantial numbers of patients who develop metastatic disease, of which up to 70% involves spread to bone, resulting in skeletal complications...
10.
Welberry Smith M, Zougman A, Cairns D, Wilson M, Wind T, Wood S, et al.
Kidney Int
. 2013 Jun;
84(6):1214-25.
PMID: 23739232
Early identification and prognostic stratification of delayed graft function following renal transplantation has significant potential to improve outcome. Mass spectrometry analysis of serum samples, before and on day 2 post...